Presentation for Second Meeting of the Global TB/HIV Working Group

Slides:



Advertisements
Similar presentations
TB/HIV Research Priorities in Resource- Limited Settings Where we are now and some suggestions for where to go Paul Nunn February 2005.
Advertisements

Strategic Information for Anti-RetroViral Treatment Programmes Workshop WHO and UNAIDS Geneva June 30- July Ties Boerma HIV Department Surveillance,
An operational package for Integrated Management of HIV/AIDS prevention, treatment and care ICASA - Abuja, Nigeria 5 December 2005.
February Dakar, Senegal
The U.S. President’s Emergency Plan for AIDS Relief The Evolving HIV Prevention Strategy for IDUs in PEPFAR Amb. Eric Goosby US Global AIDS Coordinator.
JOINT TB AND HIV PROGRAMMING AND SINGLE CONCEPT NOTE Haileyesus Getahun Global TB Programme, WHO.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Kevin Fenton, MD, PhD, FFPH Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention.
Concept Note on HIV Mongolia Process and key components of Funding Request to Global Fund.
Tools for HIV/TB Integration and the Civil Society Experience Carol Nawina Nyirenda Executive Director Community Initiative for Tuberculosis, HIV/AIDS.
Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.
Unit 8: Uses and Dissemination of HIV Sentinel Surveillance Data #3-8-1.
FHI’s Global ART Program: Today's snapshot and tomorrow's vision 10 August 2010 Kwasi Torpey, MD, PhD, MPH Regional Senior Technical Advisor, FHI 8 th.
5 th DOTS Expansion Working Group Meeting, Paris, October 28, 2004 Tuberculosis and HIV - Future Directions Paul Nunn, Stop TB Dept., WHO, Geneva GLOBAL.
Enabling Continuity of a Public Health ARV Treatment program in a resource limited setting: The Case of the transition of the African Comprehensive HIV/AIDS.
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
Missed opportunities to diagnose TB and HIV Co-infection in HIV workplace program Dr Fred Mugyenyi Asiimwe Medical Director, ALAFA.
Monitoring &Evaluation System in Health Program. Brief overview of NACP Reporting units and quality aspects Data sets Learning/ Analysis of the data sets.
Monitoring UA 2010 in health sector 1 |1 | Monitoring progress towards Universal Access 2010 in the health sector Kevin M De Cock Ties Boerma.
TB/HIV COLLABORATION IN GHANA Dr. Nii Nortey Hanson – Nortey National TB Control Programme Accra.
AIDS PREVALENCE IN THE WORLD. AIDS EVAPORATES GAINS OF THE 20 TH CENTURY IN AFRICA.
XVII INTERNATIONAL AIDS CONFERENCE PANCAP Satellite Meeting Hon Douglas Slater, Minister of Health, St. Vincent and the Grenadines.
Integration of collaborative TB/HIV activities with harm reduction services Maryna Zelenskaya Ph D State service on HIV/AIDS and other socially diseases.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
TM Current Political and Social Issues in the Prevention and Treatment of HIV/AIDS in Africa Cissy Kityo Mutuluuza MD, MSc Deputy Director Research & Clinical.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Getting more value for money: working with countries and partners toward greater effectiveness and efficiency Peter Stegman, Senior Economist.
Implementing operational research for HIV treatment scale-up in resource-limited settings TB/HIV Research Priorities in Resource-Limited Settings Expert.
Challenges of Intensified TB case finding among PLHIV : Kenyan experience Dr. J. Sitienei Ministry of Health Kenya.
United Republic of Tanzania Ministry of Health & Social Welfare MINISTRY OF HEALTH AND SOCIAL WELFARE NATIONAL AIDS CONTROL PROGRAM HIV CARE AND TREATMENT.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
Moving from a commodity approach: “Fund some of everything” or “Fund what is comfortable” to An Investment approach: “Fund evidenced-based activities.
CAMBODIA Application to the Global Fund New Funding Model Tom Hiatt Global TBTEAM meeting June 2014.
HIV/AIDS Epidemic in India Trends, Lessons, Challenges & Opportunities
Overview of guidance/frameworks
Zimbabwe’s shift towards treat all: national country context
Strengthening the Focus of Municipal HIV Responses on Key Populations
Incorporating transition considerations into the new Global Fund funding cycle Mauro Guarinieri Senior Technical Adviser, Community Responses and Drug.
Progress in Implementing collaborative TB/HIV activities
Developing Communication Strategies for PMTCT  UNICEF’s PMTCT Communication Initiatives in Africa & Asia: Lessons Learned February 5, 2002 Programme.
PROGRESS BUT MORE NEEDED!
World Health Organization
WHO/AFRO Vision for TB/HIV Control.
Progress in Implementation of TB/HIV Collaborative activities
UNAIDS INTERCOUNTRY TEAM EASTERN AND SOUTHERN AFRICA
WHO global policy development process for TB/HIV
Enablers for nationwide expansion of collaborative TB/HIV activities
Integrating TB and HIV care services – Malawi Experiences
Interim TB/HIV Document
Collaborative TB/HIV services
Petchsri Sirinirund Advisor to HIV/AIDS Policy and Programme
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
Malawi ProTEST Lessons Learned
ProTEST Lessons Learned Workshop
MONITORING AND EVALUATION IN TB/HIV PROGRAMS
Introduction to poster session and discussion
Dr. Kenneth L. Chebet Director NASCOP/NLTP Division Kenya
The ProTEST Projects:Achievements so far
Care for those with HIV/TB: HBC, palliative care, CPT, IPT, STI, nutritional and psychological support. All the interventions should be considered within.
Progress of formal evaluation of ProTEST activities
Collaborative TB/HIV activities in European Region
Geneva, Switzerland June 2002
South Africa: From ProTest to Nationwide Implementation
From ProTEST to Nationwide Implementation
The STOP TB Strategy – 2009 VISION: A TB-free world
VISION I started with this and will end with it because it is important to know where we want to go. It sets the direction to take. IF YOU DON’T KNOW WHERE.
Surveillance, Monitoring and Evaluation Working Group
33rd IUATLD World Conference on Lung Health
Strategic framework for TB/HIV
Presentation transcript:

Presentation for Second Meeting of the Global TB/HIV Working Group SUPPORTING COUNTRIES IMPLEMENT COLLABORATIVE TB &HIV/AIDS ACTIVITIES: THE CASE OF THE AFRICAN REGION Presentation for Second Meeting of the Global TB/HIV Working Group 14-16 June, 2002. Durban South Africa Wilfred C. Nkhoma FOR WHO/AFRO TB & AIDS UNITS

OUTLINE OF PRESENTATION Re-stating the dual epidemic Current responses to the dual epidemic The Concept of Phased implementation of collaborative activities Conclusion

Re-stating the dual epidemic Conclusive global and Regional evidence of increased TB incidence among populations with high HIV prevalence since the advent of HIV/AIDS : HIV prevalence consistently higher among TB patients than in the general population; early diagnosis and treatment of TB in PLWHAs associated with improved quality of life and conversely, effective HIV prevention and care leading to reduced incidence of TB related morbidity and mortality The African Region is disproportionately affected by the TB &HIV/AIDS dual epidemic

Trend of TB notification rates in selected High or rising HIV prevalence Countries in Africa 1990-1998

Trend of TB notification rates in selected Low HIV prevalence countries in Africa 1990-1998

New HIV Infections by Region 1980-1999

Current responses to the dual epidemic (1) 1. Traditional vertical disease specific responses Responses undermined by: Weak programmes and health infrastructure Insufficient coverage with effective control strategies Scarce resources (technical, logistical, financial etc) Unco-ordinated efforts to cater for common clients Stigma issues Etc, etc

Current responses to the dual epidemic (2) 2. Piloting Integrated service delivery e.g ProTEST Projects [Malawi, South Africa & Zambia] Associated characteristics: Mostly designed with the sole purpose of allowing lessons to be learned and experiences to be gained Limited coverage and scope Often undertaken in ways that can not be be replicated across a whole country (e.g implemented with the support of an unsustainable level of human and financial resources). Tendency to be implemented outside general health service structures and ownership (commonly associated with/reflected institutional, or agency preferences to implement only certain activities) Piloting has allowed some lessons to be learned upon which to build large scale implementation of collaborative TB/HIV/AIDS activities.

Countrywide implementation by increment: Phased implementation of collaborative TB/HIV/AIDS activities: Effective TB & HIV/AIDS control are tasks for a life time and must be undertaken on a full scale basis and collaboratively for significant impacts Idea is to plan for a deliberate full-scale undertaking but phasing in time and scope so as to break down complex implementation issues into simple manageable tasks and stages More often than not, PHASING as opposed to PILOTING, allows lessons to be learned and experiences to be gained during the implementation process within the general health service delivery system. More importantly, it allows sufficient technical and logistic capacity to be developed at the operational level.

The approach to Phased implementation of Collaborative TB/HIV/AIDS activities Documentation and dissemination of lessons from pilot projects Development of plans of action for phased implementation of collaborative TB/HIV/AIDS activities as part of national programs (e.g Regional collaboration initiatives, development of technical networks, development of regional tools, Nairobi workshop for 8 Anglophone countries and planned workshop for selected Francophone countries in the African Region etc) Focus on collaborative delivery of a package of proven TB and HIV/AIDS prevention, care and support interventions Development of technical capacity and mobilization of financial and other resources for implementation of the package of collaborative activities Monitoring and evaluation Operational research (for performance improvement)

Surveillance, monitoring and evaluation CRITICAL TB & HIV/AIDS INTERVENTIONS FOR PHASED IMPLEMENTATION OF COLLABORATIVE ACTIVITIES Surveillance, monitoring and evaluation TB preventive therapy Preventive therapy for other common bacterial OIs in PLWHAs ARVs for HIV/AIDS Community and home based care initiatives for TB & HIV/AIDS Operational Research Prevention of HIV infection [counseling and education, IEC, condoms, STI treatment, PMTCT, safe blood initiatives, etc] VCT for HIV HIV/AIDS care and social support Diagnosis and management of other HIV/AIDS opportunistic infections Early diagnosis and effective treatment of TB based on the DOTS strategy Capacity building (infrastructural, human etc)

Expected outcomes Increased TB & HIV/AIDS detection and access to care and support Improved effectiveness and quality of care Improved efficiency of health services Better equity in TB & HIV/AIDS services delivery (allocative and technical equity) Applicability in all countries and settings Any contact with health services as an entry point for accessing TB & HIV/AIDS prevention, care and support services Standard disease specific outcomes can be used to monitor and evaluate effectiveness and cost-effectiveness of the key interventions

Conclusions Effective TB & HIV/AIDS control are tasks for a life time and must be undertaken on a full scale basis in a collaborative manner. Implementation of disease specific interventions for TB & HIV/AIDS without regard for the synergistic interaction between the two infections has not brought about significant impacts on the burden of the two diseases Current responses to the TB and HIV/AIDS epidemics, and specific piloting of collaborative implementation of TB/HIV/AIDS activities have provided some lessons upon which to plan and build large scale implementation of collaborative activities. Phased implementation of activities in time and scope is being actively promoted in the African Region as it has the added advantage of allowing lessons to be learned in the implementation process and sufficient capacity to be developed at the operational level. It also allows complex tasks to be broken down into manageable stages